These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20107947)

  • 1. Biological implications of thymectomy for myasthenia gravis.
    Okumura M; Inoue M; Kadota Y; Hayashi A; Tokunaga T; Kusu T; Sawabata N; Shiono H
    Surg Today; 2010; 40(2):102-7. PubMed ID: 20107947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
    Kuks JB; Oosterhuis HJ; Limburg PC; The TH
    J Autoimmun; 1991 Apr; 4(2):197-211. PubMed ID: 1883480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
    Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
    Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
    Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.
    Marx A; Pfister F; Schalke B; Saruhan-Direskeneli G; Melms A; Ströbel P
    Autoimmun Rev; 2013 Jul; 12(9):875-84. PubMed ID: 23535159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
    De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
    Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal deterioration of neurological symptoms and increase of serum acetylcholine receptor antibody levels after thymectomy: a case report of a cat with myasthenia gravis.
    Nagata N; Miyoshi T; Otake Y; Suzuki H; Kagawa Y; Yamagami T; Irie M
    J Vet Med Sci; 2017 Jan; 78(12):1893-1896. PubMed ID: 27593682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
    Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.
    Kuks JB; Limburg PC; Oosterhuis HJ; The TH
    Clin Exp Immunol; 1992 Feb; 87(2):246-50. PubMed ID: 1735188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
    Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
    J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.
    Ponseti JM; Caritg N; Gamez J; López-Cano M; Vilallonga R; Armengol M
    Expert Opin Biol Ther; 2009 Jan; 9(1):1-8. PubMed ID: 19063688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.